Agenda - Day 3 | EU Pharmaceutical Law Forum

Showing 2 of 2 Streams

Healthcare Data, Privacy & Compliance

Commercial Transactions

08:50 - 09:00

Opening Remarks from Chair

09:00 - 10:00

KEYNOTE PANEL Is your Data at Risk? Legal Implications of European Health Data Space

Guillaume Byk - Legislative Officer, DG SANTE, EU Commission
Chris Foreman - Chief Privacy Officer, Merck Sharp & Dohme
Kristof Van Quathem - Partner, Covington & Burling

10:00 - 10:40

DUAL DIALOGUE Round-up on Key Data Privacy Concerns and Conflicts for the Pharmaceutical Industry

Florian Zabel - Chief Privacy Officer Roche Group, F. Hoffmann-La Roche Ltd
Cristiana Spontoni - Partner, Jones Day

10:40 - 11:10

Networking Break

11:10 - 11:50

DUAL DIALOGUE New Developments in the Regulation, Conduct and Use of Real-World Evidence/Data

Arianna Greco - SVP, General Counsel Commercial, Alnylam Pharmaceuticals
Lincoln Tsang - Partner, Ropes & Gray

11:50 - 12:30

TRI DIALOGUE Utilising and Managing the Risk of Generative Artificial Intelligence in Day-to-Day Pharma Activities

Alejandro Bes - Head Legal - Engagement, Platforms and Data, Novartis
Florence Bakri-Lerer - Senior Legal Counsel, Merck
Vincent Rezzouk-Hammachi - Partner, Bird & Bird

12:30 - 13:50

Networking Lunch

13:50 - 14:30

DUAL DIALOGUE Key Developments for Advertising and Promotional Materials

Antje-Katrin Weigelt - General Counsel, Teva
Elizabeth Anne Wright - Partner, Cooley

14:30 - 15:10

DUAL DIALOGUE Compliance Challenges when Supporting Healthcare Systems: Disease Awareness Campaigns, Patient Support Programmes and Healthcare Service Delivery

Sabrina Ballet - Vice President, International Legal and Compliance, Blueprint Medicines
Marie Manley - Partner, Sidley Austin

15:10 - 15:40

Networking Break

15:40 - 16:20

DUAL DIALOGUE Corporate Disclosure Frameworks for Environmental, Social, and Governance (ESG)

Philipp Kohlhaas - Senior Legal Counsel ESG, Boehringer Ingelheim
Peter Sellar - Partner, Fieldfisher

16:20 - 17:00

DUAL DIALOGUE Revisions in Whistleblowing, Anti-Bribery, Anti-Corruption Law and Enforcement

Cristina Alexandrescu - Assistant General Counsel, GSK Biologicals
Annabelle Bruyndonckx - Partner, Simmons & Simmons

17:00 - 17:05

Close of Conference

08:50 - 09:00

Opening Remarks from Chair

Laetitia Szaller - General Counsel & Head of Compliance, Egetis Therapeutics AB

09:00 - 09:40

Transaction Trends and Deal Landscape in the Life Sciences Sector

Sally Shorthose - Partner, Bird & Bird

09:40 - 10:10

Regulatory Scrutiny on Deals: Update on Foreign Direct Investment Screening

Orion Berg - Partner, White & Case

10:10 - 10:40

Networking Break

10:40 - 11:20

DUAL DIALOGUE Advice on Key Antitrust Hurdles Impacting Commercial Transactions

Niels van Nuland - International Competition Law Counsel, Senior Director Legal, Gilead
Marion Provost - National Partner, Dechert

11:20 - 12:00

DUAL DIALOGUE How to Draft a Good Licencing Agreement

Isabella Fabbri - Senior Counsel Legal EMEA & Asia Pacific, PTC Therapeutics, Inc.
Tom Wilson - Senior Associate, Arnold & Porter

12:00 - 13:30

Networking Lunch

13:30 - 14:10

DUAL DIALOGUE Success Factors for Licensing Life Science Deals

Tinne Gilles - General Counsel | Life Science Expert, CSL Vifor
Andres Liivak - Partner, White & Case

14:10 - 14:50

DUAL DIALOGUE Key Aspects of IP and How to Avoid Litigation in Deals

Alexandra Pygall - Partner, Stephenson Harwood
Laetitia Szaller - General Counsel & Head of Compliance, Egetis Therapeutics AB

14:50 - 15:20

Networking Break

15:20 - 16:00

DUAL DIALOGUE How to Manage AI in Commercial Deals

Kathryn Robinson - Senior Legal Counsel, Isomorphic Labs
Sarah Hanson - Partner, Co-Head of the CMS Life Sciences & Healthcare Group, CMS

16:00 - 16:05

Close of Conference

Day 3Thursday, 23 May 2024 - CET/CEST (Cent Europe Summer, GMT+2)

Day 3Thursday, 23 May 2024 - CET/CEST (Cent Europe Summer, GMT+2)

Get the Latest Event Updates